Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L

Citations Over TimeTop 1% of 2020 papers

Abstract

The main protease (Mpro) of SARS-CoV-2 is a key antiviral drug target. While most Mpro inhibitors have a γ-lactam glutamine surrogate at the P1 position, we recently found that several Mpro inhibitors have hydrophobic moieties at the P1 site, including calpain inhibitors II and XII, which are also active against human cathepsin L, a host protease that is important for viral entry. In this study, we solved x-ray crystal structures of Mpro in complex with calpain inhibitors II and XII and three analogs of GC-376 The structure of Mpro with calpain inhibitor II confirmed that the S1 pocket can accommodate a hydrophobic methionine side chain, challenging the idea that a hydrophilic residue is necessary at this position. The structure of calpain inhibitor XII revealed an unexpected, inverted binding pose. Together, the biochemical, computational, structural, and cellular data presented herein provide new directions for the development of dual inhibitors as SARS-CoV-2 antivirals.

Related Papers

• → Activation of Calpain, Cathepsin-b and Caspase-3 during Transient Focal Cerebral Ischemia in Rat Model(2008)60 cited
• → Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis(2013)39 cited
• → Genetic and Pharmacologic Alteration of Cathepsin Expression Influences Reovirus Pathogenesis(2009)31 cited
• → Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B(2011)17 cited
• → Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors(2013)11 cited